Seniors who stick to the Mediterranean diet may be lowering their risk of developing Alzheimer’s disease, new research has found. Those who regularly consume fish in addition to leafy greens, oil, beans, nuts and high fiber — as per the diet — might also be able to tack years off of their own brain age, … Read more
A 19-year-old man in China has been diagnosed with the neurodegenerative condition — the youngest case ever reported. Source link
The first drug proven to slow Alzheimer’s is on sale, but most U.S. patients will not be able to receive the treatment for several months. Experts say some reasons behind the slow debut for Leqembi, from Japanese drugmaker Eisai, are minimal insurance coverage and many health systems requiring a setup that takes a long time. The drug, … Read more
Alzheimer’s disease could be diagnosed 3.5 years earlier, thanks to a simple blood test. A study conducted by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College in London found a blood test that can potentially predict the risk of developing the deliberating disease years before a clinical diagnosis is made. … Read more
A new, breakthrough drug designed to aggressively treat Alzheimer’s disease was awarded accelerated approval by the Food and Drug Administration on Friday. Leqembi — developed by Tokyo-headquartered Eisai — has been shown in trials to slow the cognitive and functional decline of people in the early stages of the illness. The accelerated approval comes amid … Read more
“Entrenched systemic racism” is a significant risk factor for Alzheimer’s disease and dementia in non-white Americans, the Department of Health and Human Services (HHS) claimed in its 2022 update on how to fight the disease. The HHS’ “National Plan to Address Alzheimer’s Disease” said black, Hispanic and low-income populations are more likely to face health-related … Read more
Still, too many people insist on casting the debate over what causes Alzheimer’s as an either-or problem, Nixon said. They chide him, arguing that his beliefs about the importance of the endosomal-lysosomal mechanism must mean that he doesn’t believe amyloid-beta has any role in the disease. “It’s like you can’t hold two relevant ideas in … Read more
In a large study, experimental drug lecanemab was able to slow down Alzheimer’s, but not stop it. Some researchers think the drug will become the first to help many patients; others have questions. Cemile Bingol/Getty Images hide caption toggle caption Cemile Bingol/Getty Images In a large study, experimental drug lecanemab was able to slow down … Read more
Alzheimer’s disease could soon be a distant memory. A revolutionary new Alzheimer’s drug named lecanemab could mark a major breakthrough in the decades-long battle against the neurological disorder, according to eye-opening Phase 3 trials. The potentially game-changing dry runs transpired in May 2021, but the results were only published Tuesday in the New England Journal … Read more
Chris Hemsworth’s “biggest fear” became a reality when the “Thor” actor found out he carries two copies of a dominant gene that puts him at a greater risk for Alzheimer’s. Doctors say, however, that while the chances of the Australian developing the memory-stealing disease may be greater, he might be able to steer clear by … Read more
Hoppy beers, in moderation, could help to reduce dementia, a study suggests. Researchers from the University of Milano-Bicocca tested four common varieties of hop flower extracts that are found in beer to see how well they would help to prevent brain protein clumping, which can lead to Alzheimer’s. Hop flower extracts are used in all … Read more
Don’t go digging for gold in your golden years. New research suggests that picking your nose could increase your risk of developing Alzheimer’s disease and related dementia. Bacteria can travel through the nasal cavity’s olfactory nerve — streamlined through a pick — reach the brain and create markers that are “a tell-tale sign of Alzheimer’s … Read more
COVID-19 can impact the risk of developing a host of neurological disorders. While long COVID’s impact on people is still being critically studied, new research found that the virus may increase the risk of developing memory problems and even Alzheimer’s in the year after initial infection. “It’s really sobering,” says epidemiologist and researcher on the … Read more
Last month, word spread that a drug was finally shown to slow Alzheimer’s disease, and overnight a 73-year-old Swedish professor made $350 million. The lucky man, Lars Lannfelt, was not particularly famous. He had done pioneering work on the disease, but it was in the 90s and belonged to a sub-field that, after a litany … Read more
An estimated 6.5 million Americans age 65 and up are living with Alzheimer’s disease. The progressive disease is devastating and can cause symptoms ranging from memory loss to seizures, according to the National Institute on Aging (NIA). With that, it’s understandable to be nervous if you find you or a loved one has been forgetful … Read more
Can meditation lower the risk of Alzheimer’s? Over-65s who practice mindfulness score better in brain tests, study finds Doctors say seniors should keep their minds busy to protect against dementia But a study suggests switching off and meditating might be even more effective French researchers looked at people who meditated once a week for 18 … Read more
Summary: A new blood sample test is capable of measuring the build-up of Alzheimer’s disease-associated amyloid-beta in the brain. Source: Hokkaido University Researchers from Hokkaido University and Toppan have developed a method to detect build-up of amyloid β in the brain, a characteristic of Alzheimer’s disease, from biomarkers in blood samples. Alzheimer’s disease is a … Read more
(left to right) Chris and Joe Claussen.Courtesy of Chris and Joe Claussen Chris and Joe Claussen watched their grandfather, then their father, die of Alzheimer’s disease. They did genetic testing that found they’re at increased risk for the disease too. They founded First Person, a company focused on the medicinal power of mushrooms. When Chris … Read more
Science has not yet arrived at a complete understanding of the causes of Alzheimer’s disease. However, recent findings have confirmed the association between personality and neuropathology, in that certain personality traits can increase Alzheimer’s risk. The results of the study conducted by Terracciano et al. show that individuals with higher neuroticism and lower conscientiousness have … Read more
The prevailing theory is that Alzheimer’s disease is caused by the buildup of amyloid plaques in the brain. However, new research finds that it is actually caused by a decline in levels of a specific protein. New research on patients with mutations published in the Journal of Alzheimer’s Disease. Contrary to a prevailing theory that … Read more